您的位置: 首页 > 农业专利 > 详情页

Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function
专利权人:
Roche GlycArt AG
发明人:
Pablo Umaña,Peter Bruenker,Claudia Ferrara,Tobias Suter
申请号:
US13759925
公开号:
US08859234B2
申请日:
2013.02.05
申请国别(地区):
US
年份:
2014
代理人:
摘要:
The present invention relates to the field of glycosylation engineering of proteins. More particularly, the present invention relates to nucleic acid molecules, including fusion constructs, having catalytic activity and the use of same in glycosylation engineering of host cells to generate polypeptides with improved therapeutic properties, including antibodies with increased Fc receptor binding and increased effector function.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充